Strategic Partnerships Cohero Health is part of Aptar Digital Health, actively pursuing collaborations with large players and biotech companies such as Enable Injections and AstraZeneca. This indicates a fertile path for co-selling, integration partnerships, and technology licensing opportunities to extend the platform’s reach in respiratory and neurological disease spaces.

Expanded Care Ecosystem The platform integrates connected inhaler sensors, mobile spirometry, and a multi-device mobile app, offering a comprehensive remote monitoring solution. This creates cross-selling opportunities with manufacturers of respiratory devices, wearables, and digital health ecosystems seeking end-to-end patient engagement and adherence analytics.

AI Health Analytics Aptar Digital Health has licensing and collaboration activity around AI-powered screening algorithms and neurological/rare disease care improvements. Leverage this to position advanced analytics, predictive insights, and personalized care pathways as premium capabilities for pharma and payer clients looking to optimize outcomes and reduce costs.

Global Innovation Network Recent partnerships with Biogen, SHL Medical, QoL Geneva, and ŌURA indicate a broad, international network focused on digital health innovation, self-injectables, and migraine research. This network provides warm introductions for pilots, co-development deals, and scaled deployments in diverse markets.

Growth Readiness With a lean team (51-200 employees) and revenue in the low millions, the company appears set for strategic channel sales and distribution partnerships rather than standalone deployments. Target VARs, medical device distributors, and healthcare IT integrators who can scale adoption and accelerate go-to-market in multiple regions.